1. Introduction

Death prediction consumer-rights regulation refers to the legal rules and principles governing products and services that use artificial intelligence (AI), genetic testing, medical records, wearable devices, actuarial models, or statistical algorithms to estimate an individual's probability of death, remaining lifespan, or risk of dying from a particular disease.

Examples include:

AI applications that predict a person's remaining life expectancy.

Genetic tests that estimate the risk of fatal hereditary diseases.

Insurance algorithms that use health data to estimate mortality risk and determine premiums.

Hospital systems that predict mortality to assist with treatment or intensive-care decisions.

Commercial longevity platforms that sell biological-age scores or personalized lifespan forecasts.

There is no single, universally applicable legal category called “death prediction consumer-rights regulation.” Instead, the relevant legal framework is assembled from consumer-protection law, data-protection law, medical-device regulation, insurance law, professional negligence principles, and constitutional protections.

The central legal question is:

How should the law protect consumers when a company makes potentially consequential claims about when, or how likely, a person is to die?

Such predictions can influence medical treatment, insurance coverage, financial planning, mental well-being, and personal autonomy. A legally responsible system must therefore address scientific reliability, transparent disclosures, privacy, discriminatory outcomes, misleading advertising, and access to remedies.

2. Principal legal issues

Accuracy and reliability

Providers should substantiate their claims, validate their models, disclose material limitations, and avoid presenting probabilistic estimates as certain predictions.

Informed consumer choice

Consumers should understand what the score means, what data generated it, how uncertain it is, and whether it is suitable for medical or financial decisions.

Privacy and data protection

Genetic, medical, and behavioral information may be sensitive. Collection, secondary use, sharing, retention, and automated profiling may trigger legal restrictions.

Fairness and non-discrimination

A mortality score should not become an unjustified basis for denying insurance, employment, medical care, or other important opportunities.

Accountability and remedies

Depending on the applicable law, consumers may seek refunds, correction of data, regulatory intervention, compensation, or other remedies for unlawful or negligent conduct.

3. Indian statutory framework

India does not have a standalone statute specifically regulating commercial death-prediction algorithms. Several existing laws may nevertheless apply, depending on how the prediction is marketed, what data it uses, and what decisions follow from it.

A. Consumer Protection Act, 2019

The Consumer Protection Act, 2019 is particularly relevant when an individual purchases a paid death-prediction service or a related health, insurance, or longevity product.

Important provisions include:

Section 2(11): Deficiency in service. A provider's failure to meet applicable contractual or legal standards may support a consumer complaint.

Section 2(28): Misleading advertisement. False descriptions, misleading guarantees, or materially deceptive representations about a product's capabilities may fall within the statutory definition.

Section 2(47): Unfair trade practices. Certain deceptive sales practices and false representations may qualify.

Section 21: Corrective action against misleading advertisements. The Central Consumer Protection Authority (CCPA) has powers to direct discontinuance or modification of misleading advertisements and impose statutory penalties in appropriate cases.

These provisions could become relevant if a company advertises that its algorithm can determine a person's exact death date, guarantees a particular lifespan without credible scientific support, or conceals material limitations while selling the service.

Important distinction: An inaccurate prediction does not automatically establish liability. The claimant must establish the relevant statutory grounds and, where required, causation and loss.

B. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 is relevant when a service processes digital personal data, such as identifiable medical information, genetic information, or health-related behavioral data.

India Code+1

Potential issues include:

Whether the processing has a lawful basis under the applicable provisions.

Whether the individual received an appropriate notice and, where required, gave valid consent.

Whether data is used for purposes beyond those communicated.

Whether reasonable security safeguards are maintained.

Whether applicable rights and complaint mechanisms are respected.

A company that collects health data to calculate longevity and then shares it with an insurer for a different purpose may raise serious legal questions.

Commencement qualification: The Act and the Digital Personal Data Protection Rules, 2025 have a phased implementation schedule. As of 5 November 2026, not all substantive obligations are yet operative; the principal remaining obligations are scheduled to commence 18 months after publication of the Rules, in May 2027. The applicable commencement notification and any subsequent amendments must be checked for the specific provision.

Press Information Bureau+1

C. Constitution of India: Article 21

Article 21 protects life and personal liberty. The constitutional right to privacy is especially relevant where government authorities or public institutions use mortality predictions to make decisions affecting medical treatment, benefits, or individual liberty.

In the private commercial sector, constitutional principles may inform legal interpretation, but a claim against a private company must also be grounded in an applicable statute, contract, tort, or other enforceable legal duty.

D. Information technology and medical regulation

Depending on the product, additional requirements may arise under:

The Information Technology Act, 2000 and applicable rules.

The Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017, where the product falls within the relevant medical-device framework.

Applicable clinical-establishment requirements and professional medical standards.

Insurance legislation and regulations governing insurers and their use of risk information.

A general wellness app that displays a non-clinical lifespan estimate is not necessarily regulated in the same way as software that makes medical predictions used to guide diagnosis or treatment.

4. Leading case laws and their relevance

There is an important limitation: the following decisions are analogous authorities, not judgments directly deciding the legality of commercial death-prediction algorithms. They establish principles that may apply to disputes involving privacy, misleading claims, medical services, and automated scoring.

Case 1: Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

Supreme Court of India · (2017) 10 SCC 1

The nine-judge bench recognized privacy as a fundamental right protected under Article 21 and Part III of the Constitution. Informational privacy is an important aspect of that protection.

Indian Kanoon+1

Application to death prediction

Suppose a public authority uses a person's genetic profile, medical history, and algorithmically generated mortality score to determine eligibility for a public benefit.

The constitutional questions may include:

Is there a valid legal basis for collecting and processing the information?

Is the purpose legitimate?

Is the intrusion necessary and proportionate?

Are safeguards available against misuse, arbitrary classification, or unauthorized disclosure?

A government policy that uses sensitive health predictions without adequate safeguards could face constitutional scrutiny.

Legal principle: Privacy is a protected constitutional interest; the use of personal data cannot be justified merely because technology makes its collection or analysis possible.

Case 2: Indian Medical Association v. V.P. Shantha (1995)

Supreme Court of India · (1995) 6 SCC 651

The Supreme Court examined when medical services fall within the definition of services under the Consumer Protection Act, 1986. It held that medical services for consideration generally fall within consumer-protection law, subject to the exclusions discussed in the judgment.

Indian Kanoon+1

Application to death prediction

Consider a hospital that sells a service predicting a patient's likelihood of dying within 30 days. The hospital presents the result as clinically reliable but uses an unsuitable model and fails to follow appropriate professional procedures.

The patient or an eligible claimant might argue that the service was deficient, depending on the facts and applicable law.

Relevant questions would include:

Was the service represented as a clinical assessment?

Were appropriate professional standards followed?

Were the limitations explained?

Did the service cause legally recognizable harm?

Legal principle: Medical services are not automatically exempt from consumer scrutiny simply because they involve professional judgment.

Case 3: Jacob Mathew v. State of Punjab (2005)

Supreme Court of India · (2005) 6 SCC 1

This decision addresses medical negligence and the standards relevant to professional criminal liability. The Court discussed the distinction between ordinary error and criminal negligence, including the need for a sufficiently high degree of negligence before criminal liability attaches.

Indian Kanoon

Application to death prediction

Imagine a clinician relies on a mortality algorithm when making a critical treatment decision. The algorithm gives a dangerously inaccurate result, and the clinician fails to exercise appropriate independent judgment.

The case may help frame the negligence analysis, but it does not establish that every incorrect AI prediction constitutes medical negligence.

A court would need to examine the professional duty, the applicable standard of care, the conduct of the clinician, causation, the harm suffered, and whether the particular form of liability requires additional elements.

Legal principle: An adverse medical outcome is not, by itself, proof of negligence; the required legal standard and the evidence matter.

Case 4: SCHUFA Holding (Scoring), Case C-634/21 (2023)

Court of Justice of the European Union · Judgment of 7 December 2023

In this case, the Court interpreted Article 22 of the EU General Data Protection Regulation (GDPR). It held that the automated calculation of a probability score can constitute automated individual decision-making where a third party relies strongly on that score in establishing, implementing, or terminating a contractual relationship.

EUR-Lex+1

Application to death prediction

Suppose a life insurer purchases an AI-generated mortality score from an external analytics company and uses that score as the decisive basis for refusing an applicant or imposing materially different contractual terms.

The reasoning in SCHUFA suggests that a score-generating company cannot necessarily avoid automated-decision rules simply because another company formally makes the final decision.

The precise result depends on the relevant jurisdiction, the statutory conditions, and any applicable exceptions.

Legal principle: A probability score can have legal significance when another organization relies on it to make consequential decisions.

This is particularly important when a consumer's estimated lifespan is converted into an insurance, lending, or eligibility decision.

Case 5: Federal Trade Commission v. Lumos Labs, Inc. (Lumosity) (2016)

United States · FTC enforcement action · Case No. 3:16-cv-00001

The US Federal Trade Commission challenged advertising claims that Lumosity's brain-training games improved performance and could reduce or delay cognitive impairment. The company agreed to a settlement that included $2 million in consumer redress.

Federal Trade Commission+1

Application to death-prediction products

A commercial longevity platform might claim that its algorithm is scientifically proven to determine an individual's lifespan or prevent premature death. If the company cannot substantiate those representations, consumer-protection authorities may challenge its marketing.

The analogy is especially strong where advertising exploits consumers' fear of disease, aging, or death.

Legal principle: Health-related marketing claims should be supported by appropriate scientific evidence. A disclaimer does not necessarily cure a misleading overall impression.

Case 6: Sorrell v. IMS Health Inc. (2011)

US Supreme Court · 564 U.S. 552

The Court considered a Vermont law restricting the sale and marketing use of identifiable prescription-related information. It struck down the challenged restrictions on First Amendment grounds because they discriminated against particular speakers and uses of information.

Justia U.S. Supreme Court Center+1

Application to death prediction

The decision illustrates that regulating health-related information can involve competing interests, including privacy, commercial expression, and public health.

However, Sorrell is not authority that companies have an unrestricted right to commercialize personal health data. Its constitutional analysis arose under US free-speech law and must not be treated as Indian law or as a universal rule.

5. Comparative legal framework

The following comparison shows how different jurisdictions may address the same product.

The laws do not apply identically. For example, the EU GDPR's protections concerning solely automated decisions are subject to specific conditions and exceptions; not every algorithmic score triggers Article 22.

6. Major consumer rights and the duties they imply

A sound regulatory framework for death-prediction services should protect the following interests.

1. Right to truthful information

Providers should accurately describe the product's purpose, scientific basis, intended population, and known limitations. Claims of clinical validation should be verifiable.

2. Right to meaningful disclosure

Consumers should be told whether the result is a statistical estimate, a clinical prognosis, or a general wellness score. A probability should not be presented as a certainty.

3. Data protection

Providers should explain what information is collected, why it is used, how long it is retained, and whether it is shared with insurers, employers, advertisers, or research organizations, as required by applicable law.

4. Protection against unsafe medical use

A commercial algorithm should not be treated as a substitute for an appropriate clinical assessment. High-impact medical decisions require suitable professional oversight and compliance with relevant standards.

5. Fair treatment and redress

Consumers should have appropriate routes to challenge inaccurate data, contest unlawful decisions, seek correction of misleading claims, and pursue compensation where the legal requirements are satisfied.

These are legal rights to the extent recognized by the applicable law; some are also recommended regulatory safeguards rather than independently enforceable rights in every jurisdiction.

7. Liability for an inaccurate death prediction

The legal outcome depends on the nature of the prediction, the representation made, and the harm caused.

A distinction is essential: a prediction that turns out to be wrong is not necessarily a legally defective prediction. Mortality estimates are inherently probabilistic. Liability is more likely to arise where the provider breaches a legal duty, makes deceptive representations, acts negligently, violates privacy requirements, or causes legally cognizable harm.

8. Illustrative hypothetical case

Consider an Indian company selling an AI service called LifeSpan Predictor. It charges customers ₹5,000 for an analysis of genetic data, medical records, and lifestyle information.

The platform tells a customer that they will die before the age of 50. The estimate is based on a model that has not been validated for the customer's population. The company also shares the result with an insurance intermediary without adequate legal authority.

The customer experiences serious distress and later discovers that the model relied on erroneous medical data.

A potential legal analysis would proceed as follows:

Consumer protection: Were the company's scientific and accuracy claims misleading? Was the paid service deficient?

Privacy: Was the collection and disclosure of the customer's data lawful under the provisions then in force?

Negligence: Did the company fail to meet an applicable standard of care, and did that failure cause legally recognizable harm?

Insurance regulation: Was the information used in a manner permitted by applicable insurance rules?

Remedies: Could the customer obtain correction, a refund, compensation, or regulatory intervention under the applicable legal framework?

The customer would not automatically win merely because the prediction was frightening or incorrect. Evidence of the company's representations, the model's methodology, the data disclosure, causation, and the applicable statutory requirements would be central.

9. Recommended regulatory reforms

A specialized framework could improve consumer protection through the following measures:

Scientific validation: Require evidence proportionate to the risk and intended use of the prediction.

Standardized disclosures: Require understandable explanations of uncertainty, intended use, and model limitations.

Independent audits: Test performance across relevant demographic and clinical groups.

Restrictions on consequential use: Establish clear safeguards for using mortality scores in insurance, employment, healthcare access, and public benefits.

Privacy-by-design: Minimize collection, restrict secondary uses, and establish appropriate security and retention controls.

Human review: Provide meaningful review for consequential decisions where automated decision-making safeguards are legally required or otherwise appropriate.

Effective remedies: Create accessible complaint procedures, corrective-action powers, and proportionate sanctions for serious violations.

These proposals would complement existing consumer, privacy, medical, and insurance laws rather than assume that every death-prediction product requires an entirely new statute.

10. Conclusion

Death prediction consumer-rights regulation sits at the intersection of consumer law, medical ethics, data protection, and algorithmic accountability.

In India, the Consumer Protection Act, 2019 can be relevant to misleading commercial claims and deficient paid services; Puttaswamy establishes the constitutional importance of privacy; and Indian Medical Association v. V.P. Shantha and Jacob Mathew provide relevant principles for medical-service and negligence disputes. The EU's SCHUFA judgment offers a particularly useful comparative precedent for algorithmic probability scores that influence consequential decisions.

None of these authorities directly establishes a universal legal prohibition on predicting death. The stronger legal position is that providers must comply with applicable requirements concerning truthful marketing, lawful data use, appropriate professional standards, and accountability for harm.

For a case-law research paper, the next useful step would be to develop this analysis into an India-focused legal memorandum with statutory provisions, case citations, and a separate section on insurance and AI-based mortality scoring.